Press Releases 2013
Boston Scientific Announces First Commercial Implants Of The Lotus™ Valve System in Europe - Nov 15, 2013
Marking a major step forward in the evolution of Transcatheter Aortic Valve Implantation (TAVI) technology, the first two commercial implants of the Boston Scientific (NYSE: BSX)...
Boston Scientific Receives CE Mark For Lotus™ Valve System - Oct 28, 2013
Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Lotus™ Valve System, the company's advanced transcatheter aortic valve replacement (TAVR) technology.
Boston Scientific Reports Favorable Six-Month Results From Lotus™ Valve System Clinical Trial - Sep 17, 2013
Boston Scientific Corporation (NYSE: BSX) reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the...
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial - May 22, 2013
Boston Scientific Corporation (NYSE: BSX) reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance...
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 - May 17, 2013
"We are pleased to present a particularly rich and diversified set of data this year at EuroPCR," said Keith Dawkins, M.D., global chief medical officer, Boston Scientific. "The primary endpoint results...
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com